Orthofix named Jon Serbousek president of global spine on an interim basis before he replaces the retiring Brad Mason as CEO of the company on Nov. 1.
Spinal Tech
Orthofix reported net sales increased 3.9 percent in the second quarter, and $500,000 in sales of the M6-C cervical disc since June, with fewer than 24 surgeons trained to use the technology.
The FDA approved Medicrea's top-loading screw device Tulip Genesis, according to Medical Device Network.
Bio2 Technologies enrolled its first index patient in its Vitrium cervical interbody trial.
Christopher Nicholas, DPM, is the lead researcher behind a study examining the effectiveness of Life Spine's Tarsa-Link Stand-Alone Wedge Fixation System, which is used to correct flat-foot deformities.
Advertisement
SeaSpine Holdings launched the Shoreline RY Cervical Interbody Implant System on the heels of the first surgery being successfully completed.
RTI Surgical's worldwide revenues increased 16 percent from $70.7 million in the same period last year to $82.3 million in the second quarter of 2019.
Alphatec priced its public offering of 10.9 million shares of common stock at $4.60 per share.
Smith & Nephew reported second quarter revenue increased 3.5 percent in 2019, with a strong performance in the company's emerging markets and sports medicine.
SeaSpine launched the Mariner Outrigger Revision System for use in revision spinal fusion procedures.